 |
|
|
| |
Hair antiretroviral (ARV) levels strongly predict virologic outcomes in ACTG A5257
|
| |
| |
Reported by Jules Levin
CROI 2018 March 4-7 Boston, MA.
Monica Gandhi MD, MPH, Igho Ofokotun MD, Peter Bacchetti PhD, Chengshi Jin PhD, Heather J. Ribaudo PhD, David W. Haas MD, Anandi N. Sheth MD, Howard Horng PhD, Nhi Phung, Karen Kuncze, Hideaki Okochi PhD, Raphael J. Landovitz MD, Jeffrey Lennox MD, Judith S. Currier MD; and the A5257 study team
|
| |
|
|
|
|
|
